Results 191 to 200 of about 84,483 (336)
Remote Follow‐Up After Colorectal Cancer Surgery: A Systematic Review
This systematic review investigated the impact of remote follow‐up in colorectal cancer on patient satisfaction and other indicators. Seven studies were included, which showed high levels of patient satisfaction. Further studies are needed to determine the effect on oncological outcomes.
Gajan Srikumar+3 more
wiley +1 more source
Costs of neoadjuvant therapy. ABSTRACT Purpose Total neoadjuvant therapy (TNT) has become the standard of care in locally advanced rectal cancer, but its economic impact is unclear. This study compares the cost of TNT with conventional neoadjuvant therapy (CNT), consisting of either short‐course radiotherapy or long‐course chemoradiotherapy, within a ...
Ishraq Murshed+6 more
wiley +1 more source
Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.
Sten Hammarström+5 more
openalex +1 more source
Carcinoembryonic antigen: characterization of binding with insoluble lectins [PDF]
J.M. MacSween, Roy Fox
openalex +1 more source
Patients with HCC undergoing liver resection and meeting the new MASLD and MetALD criteria have characteristic alterations of body composition. Patients with MASLD‐HCC have similar disease‐free survival but significantly shorter OS than other HCC aetiologies after curative‐intent therapy.
Deniz Uluk+16 more
wiley +1 more source
Immunologic and Biochemical Studies on the Carcinoembryonic Antigen-Like Substance in Human Neuroblastoma [PDF]
Tohru Sugimoto+2 more
openalex +1 more source
Mixed Neuroendocrine–Non‐Neuroendocrine Tumor of Bile Duct
The Kaohsiung Journal of Medical Sciences, EarlyView.
Lian Shen+3 more
wiley +1 more source
Polo‐Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations
PLK1 expression may serve as a biomarker for adjuvant chemotherapy resistance in CRC. This study focused on the relationship between PLK1 expression and RAS mutation, which has been reported to be highly sensitive to PLK1 inhibitors. RAS mutation with high PLK1 expression predicts poorer survival in adjuvant‐treated CRC patients.
Yasushi Tanaka+9 more
wiley +1 more source
Carcinoembryonic Antigen in Management of Colorectal Carcinoma [PDF]
S. N. Booth+5 more
openalex +3 more sources
Carcinoembryonic antigen in endoscopic brush specimens from benign and malignant gastric lesions [PDF]
J. Lindgren+6 more
openalex +1 more source